000 02237cam  2200421zi 4500
0019.877487
003CaOODSP
00520221107165004
006m     o  d f      
007cr cn|||||||||
008190806s2019    onca    obs  f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
0410 |aeng|afre
043 |an-cn---
045 |ay0y1
0861 |aH82-46/2019-PDF
24504|aThe oncology drug market : |ba high-growth, high-price therapeutic area = Le marché des médicaments oncologiques : un domaine thérapeutique à forte croissance et à prix élevé.
24631|aMarché des médicaments oncologiques : |bun domaine thérapeutique à forte croissance et à prix élevé
264 1|a[Ottawa] : |bPatented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, |c[2019]
300 |a1 online resource (1 page) : |bcolour illustrations
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aAt head of title: NPDUIS, National Prescription Drug Utilization Information System.
500 |aIssued also in HTML format.
504 |aIncludes bibliographical references.
520 |a"This analysis examines the trends in availability, pricing, treatment costs, and sales in Canadian and international oncology markets from 2009 to 2018. International markets examined include the Organisation for Economic Co-operation and Development (OECD) members, with a focus on the seven countries the PMPRB considers in reviewing the prices of patented medicines (PMPRB7): France, Germany, Italy, Sweden, Switzerland, the United Kingdom (UK), and the United States (US)."
546 |aText in English and French.
69207|2gccst|aDrugs
69207|2gccst|aPrices
69207|2gccst|aCosts
69207|2gccst|aStatistics
69207|2gccst|aMarket analysis
7101 |aCanada. |bPatented Medicine Prices Review Board.
792 |tThe oncology drug market : |w(CaOODSP)9.877490
85640|qPDF|s546 KB|uhttps://publications.gc.ca/collections/collection_2019/cepmb-pmprb/H82-46-2019.pdf
8564 |qHTML|sN/A|uhttp://www.pmprb-cepmb.gc.ca/view.asp?ccid=1453&lang=en